Matthew Yates

595 total citations
9 papers, 252 citations indexed

About

Matthew Yates is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Matthew Yates has authored 9 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Rheumatology and 2 papers in Oncology. Recurrent topics in Matthew Yates's work include Osteoarthritis Treatment and Mechanisms (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Matthew Yates is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Matthew Yates collaborates with scholars based in United States, Netherlands and United Kingdom. Matthew Yates's co-authors include Olga V. Nemirovskiy, Maureen Highkin, M. Marek Nagiec, Francis M. Sverdrup, David W. Griggs, Adam Skepner, Alireza Abdolrasouli, Silvère M. van der Maarel, Sean Shadle and Russell Wallis and has published in prestigious journals such as Journal of Medicinal Chemistry, Osteoarthritis and Cartilage and Immunology.

In The Last Decade

Matthew Yates

9 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Yates United States 8 134 33 33 27 25 9 252
Rob Nelissen Netherlands 11 291 2.2× 37 1.1× 43 1.3× 22 0.8× 12 0.5× 15 410
Xiaoxiao Xu China 11 176 1.3× 44 1.3× 26 0.8× 96 3.6× 17 0.7× 21 314
Takahito Yamasaki Japan 8 242 1.8× 57 1.7× 17 0.5× 28 1.0× 16 0.6× 15 407
Emilia Alina Barbu United States 10 99 0.7× 24 0.7× 65 2.0× 10 0.4× 72 2.9× 18 370
Shunsuke Kanada Japan 11 88 0.7× 33 1.0× 26 0.8× 28 1.0× 75 3.0× 16 397
Juliette Nguyen France 7 70 0.5× 63 1.9× 11 0.3× 28 1.0× 12 0.5× 8 230
Genia Maftzir Israel 10 120 0.9× 41 1.2× 30 0.9× 27 1.0× 14 0.6× 20 403
Bohdan P. Harvey United States 11 107 0.8× 54 1.6× 44 1.3× 11 0.4× 12 0.5× 20 411
Catherine O’Conor United States 5 153 1.1× 107 3.2× 7 0.2× 40 1.5× 33 1.3× 5 303
Anna Fossum Denmark 8 131 1.0× 20 0.6× 11 0.3× 24 0.9× 6 0.2× 9 321

Countries citing papers authored by Matthew Yates

Since Specialization
Citations

This map shows the geographic impact of Matthew Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Yates more than expected).

Fields of papers citing papers by Matthew Yates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Yates. The network helps show where Matthew Yates may publish in the future.

Co-authorship network of co-authors of Matthew Yates

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Yates. A scholar is included among the top collaborators of Matthew Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Yates. Matthew Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Campbell, Amy E., Matthew Yates, Jun Zhong, et al.. (2017). BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skeletal Muscle. 7(1). 16–16. 51 indexed citations
2.
Schnute, Mark E., Matthew D. McReynolds, Jill Chrencik, et al.. (2017). Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits. Journal of Medicinal Chemistry. 60(6). 2562–2572. 38 indexed citations
3.
Ulmasov, Barbara, Brent A. Neuschwander‐Tetri, Jinping Lai, et al.. (2016). Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice. Cellular and Molecular Gastroenterology and Hepatology. 2(4). 499–518. 25 indexed citations
4.
Bidula, Stefan, Darren W. Sexton, Matthew Yates, et al.. (2015). H‐ficolin binds Aspergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses. Immunology. 146(2). 281–291. 35 indexed citations
5.
Highkin, Maureen, Matthew Yates, Olga V. Nemirovskiy, et al.. (2011). High-Throughput Screening Assay for Sphingosine Kinase Inhibitors in Whole Blood Using RapidFire® Mass Spectrometry. SLAS DISCOVERY. 16(2). 272–277. 27 indexed citations
6.
Nemirovskiy, Olga V., David Tung, Adam Skepner, et al.. (2010). Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis. Xenobiotica. 40(8). 586–592. 10 indexed citations
7.
Sverdrup, Francis M., et al.. (2010). Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage. Osteoarthritis and Cartilage. 18(7). 948–955. 19 indexed citations
8.
Yates, Matthew, Steven L. Settle, Sue A. Yocum, et al.. (2010). IGFBP-5 Metabolism Is Disrupted in the Rat Medial Meniscal Tear Model of Osteoarthritis. Cartilage. 1(1). 43–54. 6 indexed citations
9.
Zack, Marc D., Anne‐Marie Malfait, Adam Skepner, et al.. (2009). ADAM‐8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala271. Arthritis & Rheumatism. 60(9). 2704–2713. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026